Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients (Q30449589)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

author name string

Rajendra Gharbaran

1

1 reference

Europe PubMed Central

18 August 2017

Andre Goy

2

1 reference

Europe PubMed Central

18 August 2017

Takemi Tanaka

3

1 reference

Europe PubMed Central

18 August 2017

Jongwhan Park

4

1 reference

Europe PubMed Central

18 August 2017

Chris Kim

5

1 reference

Europe PubMed Central

18 August 2017

Nafis Hasan

6

1 reference

Europe PubMed Central

18 August 2017

Swathi Vemulapalli

7

1 reference

Europe PubMed Central

18 August 2017

Sreeja Sarojini

8

1 reference

Europe PubMed Central

18 August 2017

Madalina Tuluc

9

1 reference

Europe PubMed Central

18 August 2017

Kip Nalley

10

1 reference

Europe PubMed Central

18 August 2017

Pritish Bhattacharyya

11

1 reference

Europe PubMed Central

18 August 2017

Andrew Pecora

12

1 reference

Europe PubMed Central

18 August 2017

K Stephen Suh

13

1 reference

Europe PubMed Central

18 August 2017

publication date

29 August 2013

1 reference

Europe PubMed Central

18 August 2017

Journal of Hematology & Oncology

1 reference

Europe PubMed Central

18 August 2017

6

1 reference

Europe PubMed Central

18 August 2017

62

1 reference

Europe PubMed Central

18 August 2017

https://scigraph.springernature.com/pub.10.1186/1756-8722-6-62

0 references

Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Third universal definition of myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Macrophages predict treatment outcome in Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Circulating clonotypic B cells in classic Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

An evidence ontology for use in pathway/genome databases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

The role of cytokines in classical Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Extranodal Hodgkin disease: spectrum of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Hodgkin disease: prognostic factors and treatment strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Identifying the precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease: role of the germinal center in B-cell lymphomagenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Giant cell formation in Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Hodgkin's disease: establishment and characterization of four in vitro cell lies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Reed-Sternberg cells in Hodgkin's cell lines HDLM, L-428, and KM-H2 are not actively replicating: lack of bromodeoxyuridine uptake by multinuclear cells in culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

20 June 2018

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Prognostic value of syndecan-1 expression in breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Third Universal Definition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Third Universal Definition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-6-62

21 January 2018

Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

26 November 2018

Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

26 November 2018

A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

26 November 2018

Reed-Sternberg cells cultured from morphologically unidentifiable precursors in the blood of patients with Hodgkin's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766006

26 November 2018

Varied B-cell immunophenotypes of Hodgkin/Reed-Sternberg cells in classic Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Development of Hodgkin's disease four years after autologous peripheral blood stem cell transplantation for multiple myeloma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated expression of basic fibroblast growth factor messenger ribonucleic acid in acoustic neuromas

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Hodgkin's disease: the origin of HRS (Hodgkin and Reed-Sternberg) cells]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous occurrence of Hodgkin's disease, nodal Langerhans' cell histiocytosis and multiple myeloma IgA(kappa)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndecan-1 expression--a novel prognostic marker in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of soluble syndecan-1 in Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B-cell differentiation immunophenotypes in classical Hodgkin lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: Correlation with the extent of angiogenesis and disease-progression risk in early disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/23988031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1756-8722-6-62

1 reference

Europe PubMed Central

18 August 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1756-8722-6-62

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30449589&oldid=1549353852"